Indole, a molecule made up of a six-membered benzene ring fused to a five-membered ring containing nitrogen, forms the core ...

For the first time, Akeso and Summit Therapeutics’ closely watched PD-1xVEGF bispecific antibody has shown that it can extend ...

Let’s dig into the relative performance of Azenta (NASDAQ:AZTA) and its peers as we unravel the now-completed Q2 drug ...

A Cornell-led collaboration has devised a potentially low-cost method for producing antibodies for therapeutic treatments.

A team of researchers from the University of Utah and Sethera Therapeutics has uncovered a powerful new way to build more ...

Before the drug development process commences, scientists conduct computational studies, cellular assays, and genomic and proteomic research to identify a specific target molecule, such as an RNA ...

SHELTON, CONNECTICUT / ACCESS Newswire / August 18, 2025 / NanoViricides, Inc., a publicly traded company (NYSE American:NNVC ...

Large language models (LLMs) are revolutionizing drug development. Researchers from China are exploring the applications of ...

The platform strategy of using one molecule to target an underlying biological pathway to address many different diseases can ...

The 9th MASH Drug Development Summit is the essential forum for pharmaceutical giants and innovative biotechs dedicated to ...

AbbVie has agreed to acquire Gilgamesh Pharmaceuticals’ lead pipeline asset bretisilocin, a clinical-stage candidate designed to treat moderate-to-severe major depressive disorder (MDD), for up to $1.